Diagnostic applications of cell-free and circulating tumor cell-associated miRNAs in cancer patients

References

• Cristofanilli M, Budd Gt, Ellis Mj et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N. Engl. J. Med.351(8), 781–791 (2004).
   PubMed Web of Science ®Google Scholar
• Cristofanilli M, Hayes DF, Budd GT et al. Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer. J. Clin. Oncol.23(7), 1420–1430 (2005).
   PubMed Web of Science ®Google Scholar
• Cohen SJ, Punt CJ, Iannotti N et al. Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. J. Clin. Oncol.26(19), 3213–3221 (2008).
   PubMed Web of Science ®Google Scholar
• De Bono JS, Scher HI, Montgomery RB et al. Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer. Clin. Cancer Res.14(19), 6302–6309 (2008).
   PubMed Web of Science ®Google Scholar
• Hayes DF, Cristofanilli M, Budd GT et al. Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival. Clin. Cancer Res.12(14 Pt 1), 4218–4224 (2006).
   PubMed Web of Science ®Google Scholar
• Attard G, Swennenhuis JF, Olmos D et al. Characterization of ERG, AR and PTEN gene status in circulating tumor cells from patients with castration-resistant prostate cancer. Cancer Res.69(7), 2912–2918 (2009).
   PubMed Web of Science ®Google Scholar
• Leversha Ma, Han J, Asgari Z et al. Fluorescence in situ hybridization analysis of circulating tumor cells in metastatic prostate cancer. Clin. Cancer Res.15(6), 2091–2097 (2009).
   PubMed Web of Science ®Google Scholar
• Pestrin M, Bessi S, Galardi F et al. Correlation of HER2 status between primary tumors and corresponding circulating tumor cells in advanced breast cancer patients. Breast Cancer Res. Treat.118(3), 523–530 (2009).
   PubMed Web of Science ®Google Scholar
• Jiang Y, Palma JF, Agus DB, Wang Y, Gross ME. Detection of androgen receptor mutations in circulating tumor cells in castration-resistant prostate cancer. Clin. Chem.56(9), 1492–1495 (2010).
   PubMed Web of Science ®Google Scholar
• Maheswaran S, Sequist LV, Nagrath S et al. Detection of mutations in EGFR in circulating lung-cancer cells. N. Engl. J. Med.359(4), 366–377 (2008).
   PubMed Web of Science ®Google Scholar
• Munzone E, Nolé F, Zorzino L et al. Acquisition of HER2/neu over-expression on circulating tumor cells (CTCs) in patients (pts) with advanced breast cancer (ABC) during chemotherapy. J. Clin. Oncol.26(15 Suppl.), (2008) (Abstract 11017).
   Google Scholar
• Sieuwerts Am, Kraan J, Bolt-De Vries J et al. Molecular characterization of circulating tumor cells in large quantities of contaminating leukocytes by a multiplex real-time PCR. Breast Cancer Res. Treat.118(3), 455–468 (2009).
   PubMed Web of Science ®Google Scholar
• Aktas B, Tewes M, Fehm T, Hauch S, Kimmig R, Kasimir-Bauer S. Stem cell and epithelial-mesenchymal transition markers are frequently over-expressed in circulating tumor cells of metastatic breast cancer patients. Breast Cancer Res.11(4), R46 (2009).
   PubMed Web of Science ®Google Scholar
• Fehm T, Muller V, Aktas B et al. HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trial. Breast Cancer Res. Treat.124(2), 403–412 (2010).
   PubMed Web of Science ®Google Scholar
• Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell75(5), 843–854 (1993).
   PubMed Web of Science ®Google Scholar
• Mattick JS, Makunin IV. Non-coding RNA. Hum. Mol. Genet.15(1), R17–R29 (2006).
   PubMed Web of Science ®Google Scholar
• Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat. Rev. Cancer6(11), 857–866 (2006).
   PubMed Web of Science ®Google Scholar
• Wiemer EA. The role of microRNAs in cancer: no small matter. Eur. J. Cancer43(10), 1529–1544 (2007).
   PubMed Web of Science ®Google Scholar
• Chen X, Ba Y, Ma L et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res.18(10), 997–1006 (2008).
   PubMed Web of Science ®Google Scholar
• Gilad S, Meiri E, Yogev Y et al. Serum microRNAs are promising novel biomarkers. PLoS ONE3(9), e3148 (2008).
   PubMed Web of Science ®Google Scholar
• Mitchell PS, Parkin RK, Kroh EM et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc. Natl Acad. Sci. USA105(30), 10513–10518 (2008).
   PubMed Web of Science ®Google Scholar
• Taylor DD, Gercel-Taylor C. MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol. Oncol.110(1), 13–21 (2008).
   PubMed Web of Science ®Google Scholar
• Asaga S, Kuo C, Nguyen T, Terpenning M, Giuliano AE, Hoon DS. Direct serum assay for microRNA-21 concentrations in early and advanced breast cancer. Clin. Chem.57(1), 84–91 (2011).
   PubMed Web of Science ®Google Scholar
• Brase JC, Wuttig D, Kuner R, Sultmann H. Serum microRNAs as non-invasive biomarkers for cancer. Mol. Cancer9(1), 306 (2010).
   PubMed Web of Science ®Google Scholar
• Li J, Smyth P, Flavin R et al. Comparison of miRNA expression patterns using total RNA extracted from matched samples of formalin-fixed paraffin-embedded (FFPE) cells and snap frozen cells. BMC Biotechnol.7, 36 (2007).
   PubMed Web of Science ®Google Scholar
• Kim VN. MicroRNA biogenesis: coordinated cropping and dicing. Nat. Rev. Mol. Cell Biol.6(5), 376–385 (2005).
   PubMed Web of Science ®Google Scholar
• Vasudevan S, Tong Y, Steitz JA. Switching from repression to activation: microRNAs can up-regulate translation. Science318(5858), 1931–1934 (2007).
   PubMed Web of Science ®Google Scholar
• Miranda KC, Huynh T, Tay Y et al. A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes. Cell126(6), 1203–1217 (2006).
   PubMed Web of Science ®Google Scholar
• Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell116(2), 281–297 (2004).
   PubMed Web of Science ®Google Scholar
• Lu J, Getz G, Miska EA et al. MicroRNA expression profiles classify human cancers. Nature435(7043), 834–838 (2005).
   PubMed Web of Science ®Google Scholar
• Rosenfeld N, Aharonov R, Meiri E et al. MicroRNAs accurately identify cancer tissue origin. Nat. Biotechnol.26(4), 462–469 (2008).
   PubMed Web of Science ®Google Scholar
• Rosenwald S, Gilad S, Benjamin S et al. Validation of a microRNA-based qRT-PCR test for accurate identification of tumor tissue origin. Mod. Pathol.23(6), 814–823 (2010).
   PubMed Web of Science ®Google Scholar
• Sempere LF, Christensen M, Silahtaroglu A et al. Altered microRNA expression confined to specific epithelial cell subpopulations in breast cancer. Cancer Res.67(24), 11612–11620 (2007).
   PubMed Web of Science ®Google Scholar
• Ferracin M, Veronese A, Negrini M. Micromarkers: miRNAs in cancer diagnosis and prognosis. Expert Rev. Mol. Diagn.10(3), 297–308 (2010).
   PubMed Web of Science ®Google Scholar
• Yang H, Kong W, He L et al. MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN. Cancer Res.68(2), 425–433 (2008).
   PubMed Web of Science ®Google Scholar
• Weiss GJ, Bemis LT, Nakajima E et al. EGFR regulation by microRNA in lung cancer: correlation with clinical response and survival to gefitinib and EGFR expression in cell lines. Ann. Oncol.19(6), 1053–1059 (2008).
   PubMed Web of Science ®Google Scholar
• Ji J, Shi J, Budhu A et al. MicroRNA expression, survival, and response to interferon in liver cancer. N. Engl. J. Med.361(15), 1437–1447 (2009).
   PubMed Web of Science ®Google Scholar
• Salter KH, Acharya CR, Walters KS et al. An integrated approach to the prediction of chemotherapeutic response in patients with breast cancer. PLoS ONE3(4), e1908 (2008).
   PubMed Web of Science ®Google Scholar
• Blower PE, Chung JH, Verducci JS et al. MicroRNAs modulate the chemosensitivity of tumor cells. Mol. Cancer Ther.7(1), 1–9 (2008).
   PubMed Web of Science ®Google Scholar
• Rodriguez-Gonzalez FG, Sieuwerts AM, Smid M et al. MicroRNA-30c expression level is an independent predictor of clinical benefit of endocrine therapy in advanced estrogen receptor positive breast cancer. Breast Cancer Res. Treat. DOI: 10.1007/s10549-010-0940-x (2010) (Epub ahead of print).
   PubMedGoogle Scholar
• Si Ml, Zhu S, Wu H, Lu Z, Wu F, Mo YY. miR-21-mediated tumor growth. Oncogene26(19), 2799–2803 (2007).
   PubMed Web of Science ®Google Scholar
• Meng F, Henson R, Lang M et al. Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. Gastroenterology130(7), 2113–2129 (2006).
   PubMed Web of Science ®Google Scholar
• Iorio MV, Casalini P, Piovan C et al. microRNA-205 regulates HER3 in human breast cancer. Cancer Res.69(6), 2195–2200 (2009).
   PubMed Web of Science ®Google Scholar
• Kota J, Chivukula RR, O’donnell KA et al. Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell137(6), 1005–1017 (2009).
   PubMed Web of Science ®Google Scholar
• Krutzfeldt J, Rajewsky N, Braich R et al. Silencing of microRNAs in vivo with ‘antagomirs’. Nature438(7068), 685–689 (2005).
   PubMed Web of Science ®Google Scholar
• Fabbri M, Croce CM, Calin GA. MicroRNAs in the ontogeny of leukemias and lymphomas. Leuk. Lymphoma50(2), 160–170 (2009).
   PubMed Web of Science ®Google Scholar
• Lodes MJ, Caraballo M, Suciu D, Munro S, Kumar A, Anderson B. Detection of cancer with serum miRNAs on an oligonucleotide microarray. PLoS ONE4(7), e6229 (2009).
   PubMed Web of Science ®Google Scholar
• Heneghan HM, Miller N, Lowery AJ, Sweeney KJ, Newell J, Kerin MJ. Circulating microRNAs as novel minimally invasive biomarkers for breast cancer. Ann. Surg.251(3), 499–505 (2010).
   PubMed Web of Science ®Google Scholar
• Zhao H, Shen J, Medico L, Wang D, Ambrosone CB, Liu S. A pilot study of circulating miRNAs as potential biomarkers of early stage breast cancer. PLoS ONE5(10), e13735 (2010).
   PubMed Web of Science ®Google Scholar
• Roth C, Rack B, Muller V, Janni W, Pantel K, Schwarzenbach H. Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer. Breast Cancer Res.12(6), R90 (2010).
   PubMed Web of Science ®Google Scholar
• Zhu W, Qin W, Atasoy U, Sauter ER. Circulating microRNAs in breast cancer and healthy subjects. BMC Res. Notes2, 89 (2009).
   PubMedGoogle Scholar
• Hu Z, Chen X, Zhao Y et al. Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer. J. Clin. Oncol.28(10), 1721–1726 (2010).
   PubMed Web of Science ®Google Scholar
• Silva J, Garcia V, Zaballos A et al. Vesicle-related microRNAs in plasma of NSCLC patients and correlation with survival. Eur. Respir. J.37(3), 617–623 (2011).
   PubMed Web of Science ®Google Scholar
• Brase JC, Johannes M, Schlomm T et al. Circulating miRNAs are correlated with tumor progression in prostate cancer. Int. J. Cancer128(3), 608–616 (2011).
   PubMed Web of Science ®Google Scholar
• Moltzahn F, Olshen AB, Baehner L et al. Microfluidic based multiplex qRT-PCR identifies diagnostic and prognostic microRNA signatures in sera of prostate cancer patients. Cancer Res.71(2), 550–560 (2011).
   PubMed Web of Science ®Google Scholar
• Resnick KE, Alder H, Hagan JP, Richardson DL, Croce CM, Cohn DE. The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform. Gynecol. Oncol.112(1), 55–59 (2009).
   PubMed Web of Science ®Google Scholar
• Van Niel G, Porto-Carreiro I, Simoes S, Raposo G. Exosomes: a common pathway for a specialized function. J. Biochem.140(1), 13–21 (2006).
   PubMed Web of Science ®Google Scholar
• Tsujiura M, Ichikawa D, Komatsu S et al. Circulating microRNAs in plasma of patients with gastric cancers. Br. J. Cancer102(7), 1174–1179 (2010).
   PubMed Web of Science ®Google Scholar
• Zhou H, Guo JM, Lou YR et al. Detection of circulating tumor cells in peripheral blood from patients with gastric cancer using microRNA as a marker. J. Mol. Med.88(7), 709–717 (2010).
   PubMed Web of Science ®Google Scholar
• Gui J, Tian Y, Wen X et al. Serum microRNA characterization identifies miR-885–5p as a potential marker for detecting liver pathologies. Clin. Sci.120(5), 183–193 (2011).
   PubMed Web of Science ®Google Scholar
• Yamamoto Y, Kosaka N, Tanaka M et al. MicroRNA-500 as a potential diagnostic marker for hepatocellular carcinoma. Biomarkers14(7), 529–538 (2009).
   PubMed Web of Science ®Google Scholar
• Huang Z, Huang D, Ni S, Peng Z, Sheng W, Du X. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int. J. Cancer127(1), 118–126 (2010).
   PubMed Web of Science ®Google Scholar
• Ng EK, Chong WW, Jin H et al. Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut58(10), 1375–1381 (2009).
   PubMed Web of Science ®Google Scholar
• Pu XX, Huang GL, Guo HQ et al. Circulating miR-221 directly amplified from plasma is a potential diagnostic and prognostic marker of colorectal cancer and is correlated with p53 expression. J. Gastroenterol. Hepatol.25(10), 1674–1680 (2010).
   PubMed Web of Science ®Google Scholar
• Li A, Omura N, Hong SM et al. Pancreatic cancers epigenetically silence SIP1 and hypomethylate and overexpress miR-200a/200b in association with elevated circulating miR-200a and miR-200b levels. Cancer Res.70(13), 5226–5237 (2010).
   PubMed Web of Science ®Google Scholar
• Ho AS, Huang X, Cao H et al. Circulating miR-210 as a novel hypoxia marker in pancreatic cancer. Transl. Oncol.3(2), 109–113 (2010).
   PubMed Web of Science ®Google Scholar
• Wong TS, Liu XB, Wong BY, Ng RW, Yuen AP, Wei WI. Mature miR-184 as potential oncogenic microRNA of squamous cell carcinoma of tongue. Clin. Cancer Res.14(9), 2588–2592 (2008).
   PubMed Web of Science ®Google Scholar
• Zhang C, Wang C, Chen X et al. Expression profile of microRNAs in serum: a fingerprint for esophageal squamous cell carcinoma. Clin. Chem.56(12), 1871–1879 (2010).
   PubMed Web of Science ®Google Scholar
• Chen JF, Mandel EM, Thomson JM et al. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat. Genet.38(2), 228–233 (2006).
   PubMed Web of Science ®Google Scholar
• Miyachi M, Tsuchiya K, Yoshida H et al. Circulating muscle-specific microRNA, miR-206, as a potential diagnostic marker for rhabdomyosarcoma. Biochem. Biophys. Res. Commun.400(1), 89–93 (2010).
   PubMed Web of Science ®Google Scholar
• Pigati L, Yaddanapudi SC, Iyengar R et al. Selective release of microRNA species from normal and malignant mammary epithelial cells. PLoS ONE5(10), e13515 (2010).
   PubMed Web of Science ®Google Scholar
• Ji X, Takahashi R, Hiura Y, Hirokawa G, Fukushima Y, Iwai N. Plasma miR-208 as a biomarker of myocardial injury. Clin. Chem.55(11), 1944–1949 (2009).
   PubMed Web of Science ®Google Scholar
• El-Hefnawy T, Raja S, Kelly L et al. Characterization of amplifiable, circulating RNA in plasma and its potential as a tool for cancer diagnostics. Clin. Chem.50(3), 564–573 (2004).
   PubMed Web of Science ®Google Scholar
• Katoh T, Sakaguchi Y, Miyauchi K et al. Selective stabilization of mammalian microRNAs by 3´ adenylation mediated by the cytoplasmic poly(A) polymerase GLD-2. Genes Dev.23(4), 433–438 (2009).
   PubMed Web of Science ®Google Scholar
• Zen K, Zhang CY. Circulating microRNAs: a novel class of biomarkers to diagnose and monitor human cancers. Med. Res. Rev. DOI: 10.1002/med.20215 (2010) (Epub ahead of print).
   PubMedGoogle Scholar
• Kosaka N, Iguchi H, Yoshioka Y, Takeshita F, Matsuki Y, Ochiya T. Secretory mechanisms and intercellular transfer of microRNAs in living cells. J. Biol. Chem.285(23), 17442–17452 (2010).
   PubMed Web of Science ®Google Scholar
• Skog J, Wurdinger T, Van Rijn S et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat. Cell Biol.10(12), 1470–1476 (2008).
   PubMed Web of Science ®Google Scholar
• Mostert B, Sleijfer S, Foekens JA, Gratama JW. Circulating tumor cells (CTCs): detection methods and their clinical relevance in breast cancer. Cancer Treat. Rev.35(5), 463–474 (2009).
   PubMed Web of Science ®Google Scholar
• Breton F, Bennetau B, Lidereau R et al. A mesofluidic multiplex immunosensor for detection of circulating cytokeratin-positive cells in the blood of breast cancer patients. Biomed. Microdevices13(1), 1–9 (2011).
   PubMed Web of Science ®Google Scholar
• Allard WJ, Matera J, Miller MC et al. Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin. Cancer Res.10(20), 6897–6904 (2004).
   PubMed Web of Science ®Google Scholar
• Lin Z, Wang X, Fewell C, Cameron J, Yin Q, Flemington EK. Differential expression of the miR-200 family microRNAs in epithelial and B cells and regulation of Epstein–Barr virus reactivation by the miR-200 family member miR-429. J. Virol.84(15), 7892–7897 (2010).
   PubMed Web of Science ®Google Scholar
• Mestdagh P, Van Vlierberghe P, De Weer A et al. A novel and universal method for microRNA RT-qPCR data normalization. Genome Biol.10(6), R64 (2009).
   PubMed Web of Science ®Google Scholar
• Sieuwerts Am, Kraan J, Bolt J et al. Anti-epithelial cell adhesion molecule antibodies and the detection of circulating normal-like breast tumor cells. J. Natl Cancer Inst.101(1), 61–66 (2009).
   PubMed Web of Science ®Google Scholar
• Mostert B, Kraan J, Bolt-De Vries J et al. Detection of circulating tumor cells in breast cancer may improve through enrichment with anti-CD146. Breast Cancer Res. Treat. DOI: 10.1007/s10549-010-0879-y (2010) (Epub ahead of print).
   PubMedGoogle Scholar
• Gascoyne PR, Noshari J, Anderson TJ, Becker FF. Isolation of rare cells from cell mixtures by dielectrophoresis. Electrophoresis30(8), 1388–1398 (2009).
   PubMed Web of Science ®Google Scholar
• Crosby ME, Kulshreshtha R, Ivan M, Glazer PM. MicroRNA regulation of DNA repair gene expression in hypoxic stress. Cancer Res.69(3), 1221–1229 (2009).
   PubMed Web of Science ®Google Scholar
• Foekens JA, Sieuwerts AM, Smid M et al. Four miRNAs associated with aggressiveness of lymph node-negative, estrogen receptor-positive human breast cancer. Proc. Natl Acad. Sci. USA105(35), 13021–13026 (2008).
   PubMed Web of Science ®Google Scholar
• Fasanaro P, Greco S, Lorenzi M et al. An integrated approach for experimental target identification of hypoxia-induced miR-210. J. Biol. Chem.284(50), 35134–35143 (2009).
   PubMed Web of Science ®Google Scholar
• He L, Hannon GJ. MicroRNAs: small RNAs with a big role in gene regulation. Nat. Rev. Genet.5(7), 522–531 (2004).
   PubMed Web of Science ®Google Scholar